X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30) 30
humans (26) 26
oncology (26) 26
chemotherapy (18) 18
lung cancer (17) 17
male (17) 17
aged (16) 16
female (16) 16
middle aged (16) 16
lung neoplasms - pathology (13) 13
article (11) 11
cancer (11) 11
lung neoplasms - drug therapy (11) 11
respiratory system (10) 10
adult (9) 9
lung neoplasms - therapy (9) 9
mutation (9) 9
non-small cell lung cancer (9) 9
carcinoma, non-small-cell lung - pathology (8) 8
aged, 80 and over (7) 7
erlotinib (7) 7
lung neoplasms - genetics (7) 7
lung neoplasms - mortality (7) 7
nsclc (7) 7
antineoplastic agents - therapeutic use (6) 6
carboplatin (6) 6
carcinoma, non-small-cell lung - drug therapy (6) 6
carcinoma, non-small-cell lung - therapy (6) 6
immunotherapy (6) 6
open-label (6) 6
patients (6) 6
prognosis (6) 6
therapy (6) 6
treatment outcome (6) 6
adenocarcinoma (5) 5
carcinoma, non-small-cell lung - mortality (5) 5
care and treatment (5) 5
cisplatin (5) 5
crizotinib (5) 5
neoplasm staging (5) 5
non-small cell lung carcinoma (5) 5
survival (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cell lung-cancer (4) 4
database (4) 4
etoposide (4) 4
lung cancer, non-small cell (4) 4
maintenance chemotherapy (4) 4
metastases (4) 4
non–small cell lung cancer (4) 4
trial (4) 4
tumors (4) 4
abridged index medicus (3) 3
brain neoplasms - secondary (3) 3
cardiac & cardiovascular systems (3) 3
chemoradiotherapy (3) 3
clinical trials as topic (3) 3
disease-free survival (3) 3
editorial (3) 3
egfr (3) 3
expression (3) 3
follow-up studies (3) 3
gefitinib (3) 3
growth (3) 3
inhibitor (3) 3
lung cancer, small cell (3) 3
lymphoma (3) 3
molecular targeted therapy (3) 3
multicenter (3) 3
neoplasms (3) 3
paclitaxel (3) 3
pemetrexed (3) 3
pharmacology & pharmacy (3) 3
phase-iii trial (3) 3
prevention (3) 3
protein-tyrosine kinase (3) 3
radiation (3) 3
radiation-therapy (3) 3
radiotherapy (3) 3
receptor, epidermal growth factor - genetics (3) 3
solid tumors (3) 3
surgery (3) 3
survival analysis (3) 3
targeted therapy (3) 3
tyrosine kinase inhibitors (3) 3
united states (3) 3
vinorelbine plus cisplatin (3) 3
young adult (3) 3
1st-line treatment (2) 2
adenocarcinoma - therapy (2) 2
adjuvant chemotherapy (2) 2
adolescent (2) 2
animals (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibody-response (2) 2
brain metastases (2) 2
cancer patients (2) 2
carcinoma (2) 2
carcinoma, non-small-cell lung - epidemiology (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 12/2018, Volume 19, Issue 12, pp. 1555 - 1557
Journal Article
Cancer Treatment and Research, ISSN 0927-3042, 2016, Volume 170, pp. 151 - 163
Journal Article
Oncology Times, ISSN 0276-2234, 10/2015, Volume 37, Issue 20, pp. 6 - 8
Journal Article
ONCOLOGY, ISSN 0890-9091, 11/2010, Volume 24, Issue 12, pp. 1167 - 1170
Influenza infection is a potential cause of additional morbidity and mortality in patients who are immunocompromised because of cancer or its treatment. Of... 
IMMUNIZATION | STREPTOCOCCUS-PNEUMONIAE | DISEASES | ONCOLOGY | SEASONAL INFLUENZA | REGIMEN | VIRUS VACCINE | ANTIBODY-RESPONSE | CHEMOTHERAPY | A H1N1 VACCINE | Influenza Vaccines - immunology | Time Factors | Neoplasms - immunology | Humans | Vaccination | Hematologic Neoplasms - immunology | Neoplasms, Glandular and Epithelial - immunology
Journal Article
Expert review of clinical immunology, 2015, Volume 11, Issue 8, p. 871
In this editorial, we highlight the exciting advances in immunotherapy for the treatment of non-small cell lung cancer, with nivolumab being the first... 
Carcinoma, Non-Small-Cell Lung - immunology | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Animals | United States | Humans | Immunotherapy | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Clinical Trials as Topic | Drug Approval | Lung Neoplasms - therapy
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2012, Volume 7, Issue 1, pp. 260 - 265
In the last several years, we have made slow but steady progress in developing new treatment strategies for patients with lung cancer. The use of molecularly... 
EML4-ALK | NSCLC | Erlotinib | EGFR-TK mutation | Lung cancer | Maintenance chemotherapy | MetMAb | Gefitinib | Elderly patients | Pemetrexed
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2018, Volume 24, Issue 5, pp. 1038 - 1047
Journal Article
Cancer, ISSN 0008-543X, 02/2015, Volume 121, Issue 4, pp. 631 - 639
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 3787 - 11
Journal Article
British Journal of Cancer, ISSN 0007-0920, 2019, Volume 121, Issue 3, pp. 211 - 217
BACKGROUND: This exploratory single-arm phase II study evaluated the efficacy and safety of RRx-001 followed by reintroduction of platinum plus etoposide in... 
AGENT | TRIAL | APOPTOSIS | SCLC | THERAPY | ONCOLOGY | IMMUNE-RELATED RESPONSE | NITRIC-OXIDE | OPEN-LABEL | AMRUBICIN | CHEMOTHERAPY | Infusion | Chemotherapy | Motivation | Small cell lung carcinoma | Platinum | Lung cancer | Carboplatin | Etoposide | Patients | Reintroduction | Cisplatin
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 23, pp. 2386 - 2394
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.